$0.89
3.62% today
Nasdaq, Apr 03, 07:19 pm CET
ISIN
CA14161Y2006
Symbol
CRDL
Sector
Industry

Cardiol Therapeutics Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Cardiol Therapeutics Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
100%

Cardiol Therapeutics Inc - Ordinary Shares - Class A Price Target

Target Price $8.50
Price $0.92
Potential
Number of Estimates 4
4 Analysts have issued a price target Cardiol Therapeutics Inc - Ordinary Shares - Class A 2026 . The average Cardiol Therapeutics Inc - Ordinary Shares - Class A target price is $8.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Cardiol Therapeutics Inc - Ordinary Shares - Class A to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Cardiol Therapeutics Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of . Most analysts recommend the Cardiol Therapeutics Inc - Ordinary Shares - Class A stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.37 -0.39
15.63% 5.41%
P/E negative

2 Analysts have issued a Cardiol Therapeutics Inc - Ordinary Shares - Class A forecast for earnings per share. The average Cardiol Therapeutics Inc - Ordinary Shares - Class A EPS is

$-0.39
Unlock
. This is
2.63% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.38 0.00%
Unlock
, the lowest is
$-0.40 5.26%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.37 15.63%
2025
$-0.39 5.41%
Unlock
2026
$-0.39 0.00%
Unlock
2027
$-0.23 41.03%
Unlock
2028
$0.09 139.13%
Unlock
2029
$0.38 322.22%
Unlock

P/E ratio

Current -2.45 56.17%
2025
-2.38 2.86%
Unlock
2026
-2.34 1.68%
Unlock
2027
-3.95 68.80%
Unlock
2028
9.80 348.10%
Unlock
2029
2.46 74.90%
Unlock

Current Cardiol Therapeutics Inc - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
FIRST BERLIN EQUITY RESEARCH
Locked
Locked
Locked Dec 02 2024
Analyst Rating Date
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
Locked
Dec 02 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today